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Abstract
Previous studies have reported a vasoconstrictor response in the radial artery
during a cuff-induced low-flow condition, but a similar low-flow condition in
the brachial artery results in nonuniform reactivity. This variable reactivity to
low-flow influences the subsequent flow-mediated dilatation (FMD) response
following cuff-release. However, it is uncertain whether reactivity to low-flow
is important in data interpretation in clinical populations and older adults.
This study aimed to determine the influence of reactivity to low-flow on the
magnitude of brachial artery FMD response in middle-aged and older individ-
uals with diverse cardiovascular risk profiles. Data were analyzed from 165
individuals, divided into increased cardiovascular risk (CVR: n = 115, 85M,
67.0  8.8 years) and healthy control (CTRL: n = 50, 30M, 63.2  7.2 years)
groups. Brachial artery diameter and blood velocity data obtained from Dop-
pler ultrasound were used to calculate FMD, reactivity to low-flow and esti-
mated shear rate (SR) using semiautomated edge-detection software. There
was a significant association between reactivity to low-flow and FMD in over-
all (r = 0.261), CTRL (r = 0.410) and CVR (r = 0.189, all P < 0.05) groups.
Multivariate regression analysis found that reactivity to low-flow, peak SR,
and baseline diameter independently contributed to FMD along with sex, the
presence of diabetes, and smoking (total R2 = 0.450). There was a significant
association between reactivity to low-flow and the subsequent FMD response
in the overall dataset, and reactivity to low-flow independently contributed to
FMD. These findings suggest that reactivity to low-flow plays a key role in the
subsequent brachial artery FMD response and is important in the interpreta-
tion of FMD data.
Introduction
Hemodynamic wall shear stress influences vascular home-
ostasis, and participates in the initiation and progression
of atherosclerotic cardiovascular disease (CVD) (Davies
2009). It also plays an essential role in modulating vascu-
lar endothelial function, influencing the release of
endothelium-derived vasodilators and vasoconstrictors
that determine vessel caliber. An alteration to blood flow
conditions, like those observed in high-flow (i.e., reactive
hyperemia) and low-flow states (i.e., cuff-occlusion),
alters wall shear stress with a corresponding change in
vessel diameter. During the conventional assessment of
endothelial function by brachial artery flow-mediated
dilatation (FMD), different flow conditions occur consec-
utively, that is, low-flow to high-flow (cuff-occlusion and
cuff-release, respectively). However, it remains uncertain
whether there is interplay between vessel reactivity in each
of these flow conditions, such that the FMD response is
influenced by the preceding vascular response to low-flow
and low wall shear stress. This is an important considera-
tion because a pronounced vasoconstriction during cuff-
occlusion may reduce the subsequent dilatation during
FMD, influencing the interpretation of the response.
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Previous studies (Gori et al. 2008, 2010) have reported
a vasoconstriction in the radial artery during a cuff-in-
duced low-flow condition. However, a similar low-flow
condition in the brachial artery results in vasoconstriction
in some, vasodilatation in others, and no response in
some individuals (Thijssen et al. 2008; Weissgerber et al.
2010; Harrison et al. 2011; Spiro et al. 2011; Rakobow-
chuk et al. 2012). This nonuniform reactivity to low-flow
has recently been shown to influence the subsequent bra-
chial artery FMD response (Harrison et al. 2011; Spiro
et al. 2011; Irace et al. 2016), challenging the interpreta-
tion of a diminished FMD response due to aging or the
presence of cardiovascular risk factors and/or CVD. For
example, a diminished FMD response is typically inter-
preted as impaired endothelial function (Corretti et al.
2002) or as a result of reduced hyperemic stimulus
(Mitchell et al. 2004). However, in healthy cohorts, a
diminished FMD response has also been shown to occur
if there is reactivity (vasoconstriction) to the low-flow
condition that occurs during cuff-occlusion prior to
FMD. There are few data available to demonstrate
whether reactivity to low-flow is important in data inter-
pretation in clinical populations (Spiro et al. 2011), such
as patients with cerebrovascular disease and CVD. In par-
ticular, it remains uncertain whether vasoconstriction
during low-flow explains the blunted FMD typically
observed in patients with CVD and whether this has clini-
cal relevance.
The aim of this study was to determine if vasoreactivity
to low-flow occurs in a clinical cohort with elevated car-
diovascular risk and, if so, whether this influences the
magnitude of FMD response in the brachial artery. We
also aimed to determine the influence of cardiovascular
risk factors and/or CVD, baseline arterial diameter, and
estimated hyperemic wall shear stress on the reactivity to
low-flow. We hypothesized that (1) reactivity to low-flow
would be positively associated with the magnitude of
FMD response, irrespective of the presence of cardiovas-
cular risk factors and/or CVD, and (2) the magnitude of
reactivity to low-flow would independently contribute to
the magnitude of FMD response.
Material and Methods
Participants
One hundred and sixty-five individuals (115 males,
65.8  8.5 years) participated and were allocated to two
groups: Increased cardiovascular risk (CVR: n = 115, 85
males, 67.0  8.8 years) or healthy control (CTRL:
n = 50, 30 males, 63.2  7.2 years). Individuals were
allocated to CVR if they had previously been diagnosed
as having had a stroke/transient ischemic attack, coronary
artery disease, peripheral artery disease, type 2 diabetes,
hypertension and/or dyslipidemia. Participants in CVR
were in a stable condition at the time of the study visit
with appropriate medical treatments. Participants allo-
cated to CTRL had no overt CVD, type 2 diabetes, hyper-
tension, or dyslipidemia. In the morning of the study
visit, participants were asked to abstain from taking any
medications and caffeinated beverages. UK National
Research Ethics Service South West Committee approved
all study procedures and written informed consent was
obtained from all participants.
Experimental procedures
All experimental procedures were conducted in a temper-
ature-controlled room. Participants arrived at our depart-
ment after an overnight fast, had blood samples drawn,
consumed a standardized meal and rested supine for
20 min before initiation of the protocol.
Brachial artery reactivity was assessed noninvasively
using a reactive hyperemia technique, following estab-
lished guidelines (Corretti et al. 2002; Thijssen et al.
2011) and previously described by us elsewhere (Gates
et al. 2007; Gilchrist et al. 2013; Bond et al. 2015a,b).
Briefly, subjects lay supine on an examining bed with the
right arm supported and fixed in position using a posi-
tioning pillow on a metal table. A small blood pressure
cuff was placed around the proximal part of the forearm
at least 2 cm below the antecubital fossa. A Doppler
ultrasound machine with a multifrequency linear array
transducer (SSD-5500 SV, Aloka, Tokyo, Japan) was used
to obtain a two-dimensional image of the brachial artery.
Once the optimal ultrasound image (clear lumen/arterial
wall interface) was obtained, the transducer was then
clamped using a custom-made transducer holder to pre-
vent movement.
Baseline brachial artery image and blood velocity were
recorded for 60 cardiac cycles. Following the baseline
recording, reactive hyperemia was induced by rapidly
inflating the forearm blood pressure cuff (AI6, Hokanson,
Bellevue, WA) to 250 mmHg to occlude forearm blood
flow for 5 min. At 5 min, the cuff was rapidly deflated.
Recording of the brachial artery image and blood velocity
was restarted 30 sec before deflation and continued until
3 min following deflation.
All brachial artery images and blood velocity (Doppler
spectral envelops) were recorded and analyzed by the
same investigator using dedicated software (Vascular
Research Tools, version 5.8.6, Medical Imaging Applica-
tions LLC, Coralville, IA). FMD was calculated as the
maximum percentage changes in diameter after cuff-defla-
tion compared to baseline diameter. Reactivity to low-
flow was calculated as the percentage change in diameter
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during the last 30-sec of cuff-occlusion (during low-flow)
compared to baseline diameter. Reactivity to the low-flow
condition was categorized as vasoconstriction (<0% of
baseline diameter), no response (equal to baseline diame-
ter), and vasodilatation (>0% of baseline diameter). Com-
posite vasoreactivity was calculated as the change in
diameter from low-flow to peak FMD diameter, as a per-
centage of the diameter measured at low-flow. Shear rate
(SR) was estimated by the following equation:
(4 9 MBV)/diameter (s1), where MBV is mean blood
velocity at a respective time point (cm s1). Peak SR and
SR difference (baseline SR minus SR during low-flow)
were estimated from the above equation. SR area under
the curve until time to peak dilatation (SR aucttp) was
also calculated.
Statistical analysis
All data were presented as means  SD for variables with
normal distribution, and median (interquartile range) for
variables with skewed distribution. Categorical variables
between CTRL and CVR were compared using a
Table 1. Selected characteristics and medical history of the study participants.
Overall Control CVR
Age, years 65.0 (62.0–72.0) 64.0 (60.0–67.0) 66.0 (62.8–74.0)*
Sex (M/F), n 115/50 30/20 85/30
BMI, kg m2 27.1  4.0 25.0  3.1 28.1  4.0*
Total CHOL, mmol L1 4.55 (3.78–5.50) 5.50 (4.95–6.20) 4.10 (3.48–4.80)*
LDL CHOL, mmol L1 2.47 (1.77–3.31) 3.29 (2.75–3.91) 2.13 (1.60–2.78)*
HDL CHOL, mmol L1 1.43 (1.16–1.75) 1.72 (1.39–2.04) 1.33 (1.09–1.59)*
TG, mmol L1 1.03 (0.82–1.53) 0.92 (0.74–1.29) 1.10 (0.85–1.60)*
FG, mmol L1 5.25 (4.80–5.70) 5.00 (4.80–5.50) 5.35 (4.70–5.80)*
Systolic BP, mmHg 140.7  16.2 139.1  16.3 141.4  16.1
Diastolic BP, mmHg 79.4  8.9 79.1  9.0 79.6  8.92
Stroke/TIA, n 89 0 89*
CAD, n 14 0 14*
PAD, n 2 0 2
Type 2 Diabetes, n 18 0 18*
Hypertension, n 83 0 83*
Dyslipidemia, n 92 0 92*
Current smoking, n 8 2 6
Current Medications
Biguanides, n 14 0 14*
Sulfonylureas, n 2 0 2
DPP-4 inhibitors, n 1 0 1
Insulin, n 1 0 1
a-blockers, n 5 1† 4
b-blockers, n 19 0 19*
ACE inhibitors, n 41 0 41*
ARBs, n 13 0 13*
CCBs, n 29 0 29*
Nitrates, n 2 0 2
Diuretics, n 26 0 26*
Statins, n 93 0 93*
Anticoagulants, n 2 0 2
Antiplatelets, n 90 1‡ 90*
HRT, n 1 1 1
CVR, increased cardiovascular risk group; BMI, body mass index; CHOL, cholesterol; LDL, low-density lipoprotein; HDL, high-density lipopro-
tein; TG, triglycerides; FG, fasting glucose; BP, blood pressure; TIA, transient ischemic attack; CAD, coronary artery disease; PAD, peripheral
artery disease; DPP-4, dipeptidyl peptidase-4; ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; CCB, calcium channel
blocker; HRT, hormone replacement therapy.
Data are presented as means  SD or median (interquartile range).
*Significantly different from the control group (P < 0.05).
†Prescribed for benign prostate enlargement.
‡prescribed for a condition associated with postorthopedic surgery.
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chi-square test. Independent samples t-tests were used
to examine the differences in variables between CTRL
and CVR. Pearson’s correlation coefficients were used
to examine univariate associations between reactivity to
low-flow and the magnitude of FMD response. A step-
wise multivariate regression analysis was performed in a
pooled dataset to determine the contribution of reactiv-
ity to low-flow and estimated SR indices to the magni-
tude of FMD response. A log-transformation was
performed for variables with a skewed distribution (e.g.,
FMD) before statistical analysis. Statistical analysis was
performed using IBM SPSS Statistics 22 (IBM, Armonk,
NY). Significance was set at P < 0.05. A post hoc
power calculation showed that we had 92.7% power to
detect a statistically significant association between reac-
tivity to low-flow and the magnitude of FMD response
in this study.
Results
Subject characteristics and brachial artery
hemodynamic indices
Selected subject characteristics are presented in Table 1.
Compared to CTRL, CVR was older and greater in BMI
(both P < 0.05). Total and LDL cholesterol were lower in
CVR than CTRL (both P < 0.05). HDL cholesterol was
lower in CVR than CTRL (P < 0.05). Triglycerides levels
and blood glucose concentration were higher in CVR
than CTRL (P < 0.05). Blood pressure was similar
between the groups. Brachial artery hemodynamic indices
are presented in Table 2. All indices were similar between
the groups.
Association between reactivity to low-flow
and FMD
During the cuff-induced low-flow condition, vasoconstric-
tion was exhibited by 95 (58%) out 165 individuals [31
(62%) in CTRL and 64 (56%) in CVR]. In contrast,
vasodilatation was exhibited by 68 (41%) of 165 individu-
als [18 (36%) in CTRL and 50 (43%) in CVR]. Two
(1%) of 165 individuals [one (2%) in CTRL and one
(1%) in CVR] did not show any response during this
time period. Figure 1 shows a univariate association
between reactivity to low-flow and FMD in overall (1),
CTRL (2), and CVR (3). There was a significant correla-
tion between FMD and reactivity to low-flow in all data-
sets: Overall (r = 0.261), CTRL (r = 0.410) and CVR
(r = 0.189, all P < 0.05). Adjustments for age and sex did
not alter the observed relationships.
Contribution of low-flow reactivity to FMD
in the overall dataset
A stepwise multivariate regression analysis was performed
in the pooled dataset. When age, sex, current smoking,
medical history (the presence of cardio- and cerebrovas-
cular disease, hypertension, type 2 diabetes and/or dyslipi-
demia), systolic blood pressure, estimated SR indices,
baseline brachial diameter, and reactivity to low-flow were
included in the model, peak SR (b = 0.301), reactivity to
low-flow (b = 0.271), and baseline brachial diameter
(b = 0.454) independently contributed to the magni-
tude of FMD response (R2 = 0.380 for those 3 variables)
in addition to sex, the presence of type 2 diabetes, and
current smoking (R2 = 0.450 for overall).
Table 2. Selected brachial artery structural and hemodynamic indices of the study participants.
Overall Control CVR
D base, mm 3.85 (3.38–4.27) 3.85 (3.06–4.35) 3.90 (3.44–4.26)
D low-flow, mm 3.80  0.66 3.71  0.76 3.83  0.61
SR diff, sec1 48.6 (34.1–77.3) 45.2 (31.4–72.5) 49.4 (34.6–78.2)
Low-flow reactivity, % 0.38  1.59 0.35  1.69 0.39  1.55
D peak, mm 3.94  0.64 3.86  0.74 3.98  0.59
FMD, % 3.26 (2.04–4.91) 3.37 (1.83–5.82) 3.12 (2.18–4.80)
Composite reactivity, % 4.07 (2.14–5.21) 4.20 (2.42–5.27) 3.86 (1.93–5.10)
SR peak, sec 1 819.2 (676.5–1021.1) 874.2 (686.9–1053.1) 803.6 (663.0–963.4)
SR aucttp, au 25 559 (21 122–31 760) 24 468 (19 696–29 776) 25 795 (21 675–32 777)
TTP, sec 50.0 (40.0–65.0) 40.0 (35.0–56.3) 50.0 (40.0–70.0)
CVR, increased cardiovascular risk group; D base, baseline diameter; D low-flow, diameter during low-flow; SR diff, difference in shear rate; D
peak, peak diameter; FMD, flow-mediated dilatation; SR peak, peak shear rate; SR aucttp, shear rate area under the curve until peak dilata-
tion; TTP, time to peak dilatation.
Data are presented as means  SD or median (interquartile range).
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Discussion
This study demonstrates that reactivity to low-flow during
cuff-occlusion influences the magnitude of the subsequent
FMD response in the brachial artery in a clinical cohort
of middle-aged and older individuals with increased car-
diovascular risk. This association was also observed in
healthy middle-aged and older adults. Reactivity to low-
flow independently contributed to the magnitude of FMD
response in the pooled dataset, together with peak SR and
baseline diameter. These findings suggest that reactivity to
low-flow plays a key role in the magnitude of FMD
response in the brachial artery in patients and in healthy
controls.
Association between reactivity to low-flow
and the magnitude of FMD response
Our data demonstrate that brachial artery reactivity to
low-flow varies considerably between individuals from
vasoconstriction to vasodilatation, consistent with previ-
ous reports (Weissgerber et al. 2010; Harrison et al. 2011;
Spiro et al. 2011; Rakobowchuk et al. 2012). This was the
case in the clinical cohort and the healthy control group,
and reactivity to low-flow did not appear to be dependent
on cardiovascular risk status: The association between
reactivity to low-flow and the magnitude of FMD
response observed in all datasets was unaltered by the
presence of cardiovascular risk factors and/or CVD in
CVR. These observations suggest that reactivity to low-
flow influences the subsequent FMD response in the bra-
chial artery; that is, a greater vasoconstrictor response
during low-flow results in a smaller vasodilator response
after cuff-deflation and vice versa. Given that this was the
case in all groups, reactivity to low-flow may be consid-
ered as one of the key contributing factors for the magni-
tude of FMD response and an important consideration
when interpreting brachial artery FMD data.
The mechanism by which reactivity to low-flow influ-
ences the subsequent magnitude of FMD response
remains unknown. It can be speculated that the balance
between constitutive vasodilator (e.g., nitric oxide) and
vasoconstrictor (e.g., endothelin-1) substances is altered
during low-flow and the magnitude of this shift influ-
ences the extent of vasoconstriction during low-flow and
the subsequent capacity for vasodilatation during hyper-
emia. We had thought that this might reveal something
about the health status of subjects who exhibited vasocon-
striction with blunted FMD, but our data showed that
this response was no more prevalent in patients than in
healthy controls.
Alternatively, vasoreactivity during cuff-occlusion may
be a reflection of the baseline activation state of the
endothelium that is revealed during low-flow, consistent
with the suggestion by Gori et al. (2010). Our data indi-
cate that the “resting” level of endothelial activity affects
both reactivity to low-flow and the subsequent FMD
response. Activated endothelium (e.g., greater baseline
diameter) may show a reduced ability to further vasodi-
latation in response to a hyperemic stimulus, but may be
responsive to vasoconstrictor agents released during low-
flow. In this case, low-flow may produce vasoconstriction,
whereas the subsequent FMD may only be sufficient to
return the arterial diameter back toward or just beyond
the baseline (activated) diameter. It has also been sug-
gested that the vasoconstrictor agents released during
low-flow are still active at the time of peak dilatation
(Weissgerber et al. 2010; Harrison et al. 2011), such that
A
B
C
Figure 1. Univariate association between reactivity to low-flow and
FMD in the brachial artery in the overall dateset (A), CTRL (B), and
CVR (C). Ln- denotes a log-transformation. Note that a constant (2)
was added to each FMD value before log-transformation to make
all the values positive and nonzero.
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a greater vasoconstrictor response to low-flow inhibits the
magnitude of the subsequent FMD response. Conversely,
endothelium in a nonactivated state (e.g., smaller baseline
diameter) may show a blunted ability to further vasocon-
strict in response to low-flow, but may respond to a
hyperemic stimulus with a marked vasodilatation. Cross-
talk between baseline diameter, reactivity to low-flow and
FMD may therefore be dependent upon the activation
status of the endothelium at baseline.
Consistent with this notion, prior isometric handgrip
exercise caused an increase in baseline radial artery diam-
eter, a greater reactivity to low-flow, and a diminished
FMD response compared to the no-prior exercise condi-
tion (Gori et al. 2010). A greater baseline brachial diame-
ter, vasoconstriction during low-flow and diminished
FMD were also demonstrated following percutaneous
coronary intervention compared to the preintervention
condition (Spiro et al. 2011). In both of these studies, the
composite vasoreactivity (the change in diameter from
the low-flow condition to FMD) was similar between the
resting and postintervention conditions, indicating
the need to include the low-flow arterial diameter in the
interpretation of the data.
Some participants exhibited vasodilatation in response
to low-flow. A vasodilatory response to low-flow (and
low wall shear stress) is counterintuitive, but is consistent
with previous observations (Thijssen et al. 2008; Weiss-
gerber et al. 2010; Harrison et al. 2011; Spiro et al. 2011;
Rakobowchuk et al. 2012). Thijssen et al. (2008) have
postulated that local arterial pressure changes immediately
proximal to the occluding cuff may alter transmural pres-
sure gradients (Laughlin et al. 2008), inducing changes in
vasodilatation.
Contribution of reactivity to low-flow for
the magnitude of FMD response in the
overall dataset
We used a stepwise multiple regression analysis to deter-
mine the variables that independently contribute to the
FMD response in the overall dataset. We found that reac-
tivity to low-flow, peak SR, and baseline brachial artery
diameter independently contributed to the magnitude of
FMD response along with sex, the presence of diabetes,
and current smoking. This study is the first, to our
knowledge, to demonstrate significant contributions from
reactivity to low-flow in addition to baseline brachial
artery diameter and hyperemic SR to the magnitude of
FMD response in middle-aged and older individuals with
diverse cardiovascular risk profiles. Baseline diameter is a
recognized strong predictor for the magnitude of FMD
response (Herrington et al. 2001; Silber et al. 2005; Maru-
hashi et al. 2013) as well as a predictor for CVD events in
the elderly (Yeboah et al. 2007). Thus, our finding sup-
ports an association previously observed between baseline
brachial diameter and the magnitude of FMD response.
Importantly, reactivity to low-flow and peak SR also inde-
pendently contributed to the magnitude of FMD response
in this study. Baseline diameter, peak SR, and reactivity
to low-flow are each influenced by different factors: Base-
line diameter being influenced by resting endothelial tone
(Gori et al. 2008, 2010), peak SR being influenced by
forearm microvascular function (Mitchell et al. 2004;
Anderson et al. 2011), and reactivity to low-flow is postu-
lated to be influenced by endothelium-mediated vasodila-
tor as well as vasoconstrictor substances (Gori et al.
2008). In other words, the magnitude of FMD response
may be a consequence of (1) endothelial activation at the
time of assessment, (2) forearm microvascular function,
and (3) the balance between vasodilator and vasoconstric-
tor substances during low-flow. We speculate that in a
population with diminished endothelial function due to
aging, the presence of cardiovascular risk factors and/or
CVD, these three hemodynamic factors may in part deter-
mine the magnitude of FMD response in the brachial
artery.
Implications from this study
Our observation that a greater vasoconstriction during
low-flow produces a smaller FMD response indicates the
need to measure reactivity to low-flow as part of the
FMD procedure. There could be a potential role for reac-
tivity to low-flow to be a marker of endothelial function
individually or in combination with the magnitude of
FMD response (Irace et al. 2016). Reduced brachial artery
FMD itself is a well-known marker of endothelial dys-
function as well as a strong predictor of future CVD
events (Green et al. 2011). However, it is currently
unknown (1) whether the vasoconstriction during low-
flow itself is a marker of endothelial function, and (2)
whether the composite vasoreactivity is a more precise
indicator of endothelial function and accordingly more
accurately predicts future CVD events than the conven-
tional FMD does. Follow-up on the current cohort is
planned to explore if the composite vasoreactivity is a
useful predictor for future CVD events.
Limitations
We were unable to assess brachial artery stiffness which is
reported to be positively associated with the magnitude of
reactivity to low-flow in a population with variable coro-
nary artery disease risk factors (Harrison et al. 2011). We
did not assess endothelium-independent dilatation using
an exogenous nitric oxide donor (e.g., nitroglycerin).
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However, a recent study has demonstrated an endothe-
lium-dependent nature of reactivity to low-flow in the
radial artery with transradial catheterization (Dawson
et al. 2012), which in part supports our findings. Finally,
current medication usage in CVR could have influenced
our brachial artery hemodynamic indices. However, these
indices were similar between groups after statistical
adjustment for medication usage. A previous study has
also shown that acute vasoactive drug administration had
no effect on brachial artery reactivity in healthy individu-
als or coronary artery disease patients (Gokce et al. 2002).
Conclusion
This study demonstrated that reactivity to low-flow was
associated with the magnitude of FMD response in a clin-
ical cardiovascular risk cohort, a healthy middle-aged and
older cohort and in the pooled dataset of both these
cohort. Furthermore, reactivity to low-flow independently
contributed to the magnitude of FMD response in the
pooled dataset in addition to already known contributors
(baseline diameter and peak SR). These findings suggest
that in the brachial artery, reactivity to low-flow plays a
key role in the subsequent FMD response in both the
cohort with diverse cardiovascular risk and in the healthy
control group.
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